KA logo

KAKineta Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$4.55M
Vol360.00

About

Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Mercer Island, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5

Frequently Asked Questions

What is Market Cap of Kineta Inc?
What is the 52-week high for Kineta Inc?
What is the 52-week low for Kineta Inc?
What is Kineta Inc stock price today?
What was Kineta Inc stock price yesterday?
What is the PE ratio of Kineta Inc?
What is the Price-to-Book ratio of Kineta Inc?
What is the 50-day moving average of Kineta Inc?
How many employees does Kineta Inc have?

Latest KA News

View
Top Discussions

Advertisement|Remove ads.